Introduction to Ntm Lung Disease Goals Of Treatment
Let's dive into the details surrounding Ntm Lung Disease Goals Of Treatment. Join the conversation between experts Keira Cohen, MD, and Julie Philley, MD, as they discuss the
Ntm Lung Disease Goals Of Treatment Comprehensive Overview
Dr. Charles Daley from National Jewish Health discusses Should patients with macrolide-susceptible (MAC) Speaker: Sarah K. Brode, MD MPH FRCPC To support future talks like this and our work please consider becoming a
Summary & Highlights for Ntm Lung Disease Goals Of Treatment
- Dr. Charles Daley from National Jewish Health presents
- Did you miss the COPD Foundation's educational event on
- Description: Nontuberculous mycobacterial
- Co-Chairs Julie V. Philley, MD, and Kevin Winthrop, MD, MPH, discuss nontuberculous mycobacterial
- No matter what type of nontuberculous mycobacterial (
That wraps up our extensive overview of Ntm Lung Disease Goals Of Treatment.
